Results 51 to 60 of about 14,563,409 (378)
Dynamic relationship between D‐dimer and COVID‐19 severity
Since December 2019, the seriousness of coronavirus disease 2019 (COVID-19) pandemic has been on escalation (Lu, et al 2020). Coagulopathy is common in critically ill patients with COVID-19 (Tang, et al 2020b).
Yong Li +11 more
semanticscholar +1 more source
Comparisons of oncological and functional outcomes among radical retropubic prostatectomy, high dose rate brachytherapy, cryoablation and high-intensity focused ultrasound for localized prostate cancer: A prospective, controlled, nonrandomized trial [PDF]
Background: Several clinical decision rules (CDRs) are available to exclude acute pulmonary embolism (PE), but they have not been directly compared. Objective: To directly compare the performance of 4 CDRs (Wells rule, revised Geneva score, simplified ...
Buller, H.R. +14 more
core +3 more sources
Objective Although the significance of increased plasma D-dimer levels in activating coagulation and fibrinolysis has been reported, it is still controversial whether it can be used to predict the prognosis of lung cancer patients. This meta-analysis was
M. Ma +7 more
semanticscholar +1 more source
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19 [PDF]
Observational data suggest an acquired prothrombotic state may contribute to the pathophysiology of COVID-19. These data include elevated D-dimers observed among many COVID-19 patients. We present a retrospective analysis of admission D-dimer, and D-dimer trends, among 1065 adult hospitalized COVID-19 patients, across 6 New York Hospitals.
Naymagon, Leonard +18 more
openaire +2 more sources
In the recent outbreak of novel coronavirus infection worldwide, the risk of thrombosis and bleeding should be concerned. We aimed to observe the dynamic changes of D-dimer levels during disease progression to evaluate their value for thrombosis. In this
Bilian Yu +12 more
semanticscholar +1 more source
d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019
Supplemental Digital Content is available in the text. OBJECTIVES: Hypercoagulability may be a key mechanism for acute organ injury and death in patients with severe coronavirus disease 2019, but the relationship between elevated plasma levels of d-dimer,
S. Short +13 more
semanticscholar +1 more source
Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the Caerphilly Study [PDF]
We have previously reported that plasma fibrin D-dimer (a marker of turnover of cross-linked Fibrin) showed a strong and independent association with incident ischaemic heart disease (IHD) in the Caerphilly Study cohort of 1,998 men a-ed 49-65.
Lowe, G.D.O. +4 more
core +1 more source
Background Increased D-dimer levels have been shown to correlate with adverse outcomes in various clinical conditions. However, few studies with a large sample size have been performed thus far to evaluate the prognostic value of D-dimer in patients with
Ying-Wen Lin +7 more
doaj +1 more source
BackgroundD-dimer is a biomarker of fibrin production and degradation, and changes in D-dimer concentration suggest fibrin clot formation, which is associated with thromboembolism and hypercoagulable states.
Shohei Migita +11 more
doaj +1 more source
D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulates pro-thrombotic changes. This, combined with its tropism for endothelium and lung structures, may explain its association with thrombotic events, reduction of pulmonary gas
S. Vidali +6 more
semanticscholar +1 more source

